caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1134215932

Maurice SepeM.D.

Family PracticeMiami, FLI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 100022
Hospital
REFERRAL NETWORK

Where Maurice Sepe's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 5 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
PUBLIC HEALTH TRUST OF MIAMI DADE COUNTY FLORIDA65404
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
PUBLIC HEALTH TRUST OF MIAMI DADE COUNTY FLORIDA1381,102
PUBLIC HEALTH TRUST OF MIAMI DADE COUNTY FLORIDA76544
ANNE BATES LEACH EYE HOSPITAL32116
MALLON, STEPHEN2267
ALEXANDER, JOSEPH1133
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
75
Unique beneficiaries
—
Total services
180
Distinct HCPCS
2
Medicare payment
$11K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 4,914 Family Practice providers in FL — bottom quintile (cohort median 682).
PRESCRIBING · PART D · 2024
Total Rx claims
3,347
Beneficiaries
—
Total drug cost
$503K
Distinct drugs
58
Brand share
26.2%
Top prescribed drugs
Amlodipine Besylate305 claims
Rosuvastatin Calcium294 claims
Atorvastatin Calcium257 claims
Metformin Hcl186 claims
Empagliflozin118 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
Final MIPS score
91.0
Quality
73.0
Cost
78.7
Improvement activities
40.0
Promoting interop.
82.0
Payment adjustment
0.67%
Group